ST17
ST17 is a light-activated prodrug of ST13 that rapidly releases ST13 upon irradiation. ST13 is a potent, slow-binding, and tight-binding inhibitor of HDAC1/HDAC2 with antiproliferative activity. ST17 is applicable in melanoma and breast cancer research.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
